Genovis

📍 Lund, Sweden🗓 Founded 1999👥 42 employees💰 Last funded May 2018
Biotechnology Research🌐 genovis.com
Website LinkedIn
Genovis offers a unique range of rapid and easy to use enzymatic tools primarily for the biopharmaceutical industry. Available worldwide, these SmartEnzymes™ are supplied in innovative formats for the development, production and quality control of biological drugs such as monoclonal antibodies, ADCs, biosimilars and bispecifics. The Genovis SmartEnzymes are widely used for the digestion, de-glycosylation and conjugation of the target molecule and are an ideal companion to popular analytical techniques like LC-MS. Within the portfolio there are enzymes specific for: IgG digestion - FabRICATOR™, FabALACTICA™, GingisKHAN™, FabULOUS™ & FabRICATOR Z™ General proteolysis - GingisREX™ De-glycosylation and conjugation of IgGs - GlycINATOR™, IgGZERO™ and GlyCLICK™ O-glycan analysis - OglyZOR™, OpeRATOR™, GlycOCATCH™ and SialEXO™
3
Total investors
0
Early stage
0
Mid stage
0
Late stage
1999
Founded

Investors

3 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Sweden
3
Investor activity2013–2018 · investors recorded per year
2013120182
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Genovis?
Genovis has 3 investors on record on gritt.io.
When did Genovis last raise funding?
The most recent investment in Genovis recorded on gritt.io was in May 2018.
When was Genovis founded?
Genovis was founded in 1999.
What industry is Genovis in?
Genovis operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Genovis based?
Genovis is headquartered in Lund, Sweden.